SREBP INHIBITOR
Disclosed are a medicinal drug, a quasi drug, a cosmetic, a food, a beverage, a pet food, a feed and others which are highly safe, have an excellent SREBP-inhibiting activity, an excellent ACC1-inhibiting activity and an excellent malonyl-CoA-inhibiting activity, and are effective for the prevention...
Saved in:
Main Authors | , , , |
---|---|
Format | Patent |
Language | English French Japanese |
Published |
20.10.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Disclosed are a medicinal drug, a quasi drug, a cosmetic, a food, a beverage, a pet food, a feed and others which are highly safe, have an excellent SREBP-inhibiting activity, an excellent ACC1-inhibiting activity and an excellent malonyl-CoA-inhibiting activity, and are effective for the prevention or amelioration of troubles associated with the abnormality in sebum or lipids, such as seborrheic alopecia and seborrheic dermatitis (eczema) or the prevention or amelioration of SREBP-associated diseases such as diabetic nephropathy or metabolic abnormality. Specifically disclosed is an SREBP inhibitor, an ACC1 inhibitor or a malonyl-CoA-inhibitor which comprises chlorogenic acid or a salt thereof as an active ingredient.
La présente invention concerne un médicament, un quasi-médicament, un cosmétique, un aliment, une boisson, un aliment pour animal de compagnie, un aliment pour bétail ou autre présentant une grande innocuité ainsi qu'une excellente activité anti-SREBP, anti-ACC1 et anti-malonyl-CoA et s'avérant efficace pour prévenir ou améliorer des troubles associés à une anomalie du sébum ou des lipides, par exemple l'alopécie séborrhéique et la dermatite séborrhéique (eczéma) ou des maladies associées aux SREBP, telles que la néphropathie diabétique ou une anomalie métabolique. L'invention concerne spécifiquement un inhibiteur des SREBP, un inhibiteur d'ACC1 ou un inhibiteur de la malonyl-CoA comprenant, en tant qu'ingrédient actif, de l'acide chlorogénique ou l'un de ses sels. |
---|---|
Bibliography: | Application Number: WO2011JP59277 |